Published • loading... • Updated
One man pins his hopes on an Australian-first trial aiming to slow Parkinson's progression
Researchers found 20 of 30 patients taking SNT-4728 had reduced brain inflammation after 12 weeks, while placebo participants showed no change.
Summary by yourlifechoices.com.au
5 Articles
5 Articles
Sydney Morning Herald+3 Reposted by 3 other sources
‘Absolutely staggering’: Results from experimental drug trial to prevent Parkinson’s disease
For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development.
·North Sydney, Australia
Read Full Article
Coverage Details
Total News Sources5
Leaning Left3Leaning Right0Center1Last UpdatedBias Distribution75% Left
Bias Distribution
- 75% of the sources lean Left
75% Left
L 75%
C 25%
Factuality
To view factuality data please Upgrade to Premium
